[시장보고서]In Vitro 진단(IVD) 시장 : 제품 유형별, 검사 유형별, 용도별, 최종사용자별, 지역별

In Vitro 진단(IVD) 시장 : 제품 유형별, 검사 유형별, 용도별, 최종사용자별, 지역별

In Vitro Diagnostics Ivd Market, By Product, By Test Type, By Application, By End User, By Geography

상품코드 : 1672714

리서치사 : Coherent Market Insights

발행일 : 2025년 02월

페이지 정보 : 영문

라이선스 & 가격 (부가세 별도)

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 In Vitro 진단(IVD) 시장은 2025년에는 1,267억 3,000만 달러로 추정되며, 2032년에는 1,970억 6,000만 달러에 달할 것으로 예측되며, 2025-2032년 CAGR은 6.5%로 추이할 것으로 예측됩니다.

리포트 범위		리포트 상세
기준연도	2024	2025년 시장 규모	1,267억 3,000만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측 기간 : 2025-2032년 CAGR :	6.50%	2032년 가치 예측	1,970억 6,000만 달러

도표. In Vitro 진단(IVD) 시장 점유율(%), 2025년 지역별

세계의 In Vitro 진단(IVD) 시장은 혈액, 소변, 조직 등의 생체 샘플을 검사하여 질병을 검출하는 것으로, IVD 기술은 질병의 조기 발견을 가능하게 하여 적시에 임상적 개입과 환자 예후를 개선하는 데 도움이 됩니다. 시장 성장의 원동력은 노인 인구 증가, 만성질환 및 감염성 질환의 유병률 증가, 보다 정확한 현장 검사 및 분자진단 검사의 개발로 이어지는 기술 발전입니다. 그러나 신제품 승인에 대한 엄격한 규제와 일부 국가의 불리한 의료 개혁이 시장 성장을 저해하는 요인으로 작용하고 있습니다.

시장 역학:

세계 체외진단(IVD) 시장은 만성질환에 취약한 노인 인구 증가, 암 및 당뇨병과 같은 생활습관병의 발병률 증가, 질병의 조기발견에 대한 인식 증가가 성장의 원동력이 되고 있습니다. 기술 발전으로 인해 현장 진료 및 가정내 검사를 위한 소형화된 휴대용 진단 플랫폼이 개발되고 있으며, 이 또한 주요 촉진요인으로 작용하고 있습니다. 그러나 신제품 승인에 대한 엄격한 규제 지침과 일부 지역의 의료보험 축소로 인해 시장 성장에 위협이 되고 있습니다. 또한 첨단 분자진단 검사에 대한 상환 정책은 국가마다 다르며, 이는 시장 성장을 저해하고 있습니다. 신흥 국가의 의료비 지출 증가는 유리한 기회를 제공합니다.

본 조사의 주요 특징

세계의 체외진단(IVD) 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 연평균 성장률(CAGR)에 대해 조사 분석하여 전해드립니다.
또한 다양한 부문에 걸친 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 인사이트를 제공합니다.
이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 체외 진단(IVD) 시장의 주요 기업을 프로파일링합니다.
이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
세계 체외진단(IVD) 의약품 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
이해관계자들은 세계 체외진단(IVD) 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

Siemens Healthineers
Sysmex Corporation
Bio-Rad Laboratories
bioMerieux S.A.
Becton Dickinson, and Company
Danaher Corporation
Abbott Laboratories
F. Hoffmann-la Roche Ltd
QIAGEN N.V.
Arkray, Inc.
Nittobo Medical Co., Ltd.
Medical & Biological Laboratories Co., Ltd.
Miraca Holdings Inc.
Mizuho Medy Co., Ltd.
Thermo Fischer Scientific Inc
Diasorin
Agilent Technologies, Inc
Grifols SA
Wheel of Fortune
Analyst View
Coherent Opportunity Map

제11장 참고 문헌과 조사 방법

참고 문헌
조사 방법

KSA

영문 목차

영문목차

Global In Vitro Diagnostics Ivd Market is estimated to be valued at USD 126.73 Bn in 2025 and is expected to reach USD 197.06 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 126.73 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.50%	2032 Value Projection:	USD 197.06 Bn

Figure. In Vitro Diagnostics Ivd Market Share (%), By Region 2025

Global in-vitro diagnostics market involves the testing of biological samples such as blood, urine, tissues, and others for detection of diseases. IVD technologies allow early detection of diseases which helps in timely clinical intervention and improved patient outcomes. The market growth is driven by rising geriatric population, increasing prevalence of chronic and infectious diseases, technological advancements leading to development of more accurate point-of-care and molecular diagnostic tests. However, stringent regulations for new product approvals and unfavorable healthcare reforms in some countries hinders the market growth.

Market Dynamics:

Global in-vitro diagnostics market growth is driven by rising geriatric population who are more prone to chronic diseases, increasing incidence of lifestyle diseases such as cancer and diabetes, and growing awareness regarding early disease detection. Technological advancements have led to the development of miniaturized and portable diagnostic platforms for point-of-care and home-based testing, which is another major growth driver. However, stringent regulatory guidelines for approval of new diagnostic products and reduced healthcare coverage in some regions pose threat to the market growth. Furthermore, reimbursement policies for advanced molecular diagnostic tests vary across countries which restrains the market growth. Growing healthcare expenditure in emerging nations offers lucrative opportunities.

Key Features of the Study:

This report provides in-depth analysis of the global in-vitro diagnostics market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global in-vitro diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study includes Siemens Healthineers, Sysmex Corporation, Bio-Rad Laboratories, bioMerieux S.A., Becton Dickinson and Company, Danaher Corporation, Abbott Laboratories, F. Hoffmann-la Roche Ltd, QIAGEN N.V., Arkray Inc., Nittobo Medical Co. , Medical & Biological Laboratories Co. Ltd., Miraca Holdings Inc., Mizuho Medy Co. Ltd., Thermo Fischer Scientific Inc, Diasorin, Agilent Technologies, Inc, and Grifols SA.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global in-vitro diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global in-vitro diagnostics market.

Market Segmentation

Product Type:
- Reagents & Kits
- Instruments
Test Type:
- Clinical Chemistry
- Immunoassay
- Hematology
- Molecular Diagnostics
- Microbiology
- Coagulation & Hemostasis Urinalysis
- Others
Application:
- Infectious Diseases
- Diabetes
- Oncology
- Cardiology
- Nephrology
- Autoimmune Disorders
- Others
End User:
- Hospitals & Clinics
- Diagnostic Laboratories
- Academic & Research Institutes
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Siemens Healthineers
- Sysmex Corporation
- Bio-Rad Laboratories
- bioMerieux S.A.
- Becton Dickinson and Company
- Danaher Corporation
- Abbott Laboratories
- Hoffmann-la Roche Ltd
- QIAGEN N.V.
- Arkray Inc.
- Nittobo Medical Co.
- Medical & Biological Laboratories Co.
- Miraca Holdings Inc.
- Mizuho Medy Co. Ltd.
- Thermo Fischer Scientific Inc
- Diasorin
- Agilent Technologies, Inc
- Grifols SA

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Test Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
PEST Analysis

4. Global In-Vitro Diagnostics Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Impact on Supply and Demand
COVID-19 Impact on the market

5. Global In-Vitro Diagnostics Market, By Product, 2020 - 2032, (US$ Billion)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Reagents & Kits
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Instruments
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

6. Global In-Vitro Diagnostics Market, By Test Type, 2020 - 2032, (US$ Billion)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Clinical Chemistry
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Immunoassay
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Hematology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Molecular Diagnostics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Microbiology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Coagulation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Global In-Vitro Diagnostics Market, By Application, 2020 - 2032, (US$ Billion)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Infectious Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Diabetes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Cardiology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Nephrology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Autoimmune Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

8. Global In-Vitro Diagnostics Market, By End User, 2020 - 2032, (US$ Billion)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Hospitals & Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Diagnostic Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

9. Global In-Vitro Diagnostics Market, By Region, 2020 - 2032, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- U.S.
- Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- North Africa
- Central Africa
- South Africa

10. Competitive Landscape

Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Sysmex Corporation
Bio-Rad Laboratories
bioMerieux S.A.
Becton Dickinson, and Company
Danaher Corporation
Abbott Laboratories
F. Hoffmann-la Roche Ltd
QIAGEN N.V.
Arkray, Inc.
Nittobo Medical Co., Ltd.
Medical & Biological Laboratories Co., Ltd.
Miraca Holdings Inc.
Mizuho Medy Co., Ltd.
Thermo Fischer Scientific Inc
Diasorin
Agilent Technologies, Inc
Grifols SA
Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us and Sales Contact

한글목차

시장 역학:

본 조사의 주요 특징

목차

제1장 조사의 목적과 전제조건

제2장 시장 전망

제3장 시장 역학, 규제, 동향 분석

제4장 세계의 In Vitro 진단(IVD) 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

제5장 세계의 In Vitro 진단(IVD) 시장, 제품별, 2020-2032년

제6장 세계의 In Vitro 진단(IVD) 시장, 검사 유형별, 2020-2032년

제7장 세계의 In Vitro 진단(IVD) 시장, 용도별, 2020-2032년

제8장 세계의 In Vitro 진단(IVD) 시장, 최종사용자별, 2020-2032년

제9장 세계의 In Vitro 진단(IVD) 시장, 지역별, 2020-2032년

제10장 경쟁 구도